Intravenous immunoglobulin in two children with Guillain-Barré syndrome

L. D. Notarangelo, M. Duse, S. Tiberti, B. Guarneri, A. Brunori, A. Negrini, A. G. Ugazio

Research output: Contribution to journalArticlepeer-review


Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.

Original languageEnglish
Pages (from-to)372-374
Number of pages3
JournalEuropean Journal of Pediatrics
Issue number4
Publication statusPublished - Apr 1993


  • Guillain-Barrè syndrome
  • Intravenous immunoglobulin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Intravenous immunoglobulin in two children with Guillain-Barré syndrome'. Together they form a unique fingerprint.

Cite this